Erb B2 is well known to be overexpressed commonly in pancreatic cancers [28], [29] so this might be a possible mechanism by which forced PTK6 overexpression in pancreatic cancer cells could activates ERK1/2 without ERK5 activity. This evidence concerns the gene MAPK3 and pancreatic neoplasm.